The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Final overall survival (OS) results from SOLO2/ENGOT-ov21: A phase III trial assessing maintenance olaparib in patients (pts) with platinum-sensitive, relapsed ovarian cancer and a BRCA mutation.
 
Andres Poveda
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; PharmaMar; Roche; Tesaro
Travel, Accommodations, Expenses - PharmaMar
 
Anne Floquet
Consulting or Advisory Role - Astra Zeneca; CLOVIS ONCOLOGY; GSK; MSD Oncology; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; GSK; MSD Oncology; Roche; Tesaro
 
Jonathan A. Ledermann
Honoraria - AstraZeneca/MedImmune
Consulting or Advisory Role - Artios; AstraZeneca/MedImmune; Clovis Oncology; Cristal Therapeutics; Esai; Merck; Pfizer; Seattle Genetics; Tesaro
Speakers' Bureau - Clovis Oncology; Pfizer; Tesaro/GSK
Research Funding - AstraZeneca (Inst); MSD Oncology (Inst)
Travel, Accommodations, Expenses - Clovis
Other Relationship - Regeneron
 
Rebecca Asher
No Relationships to Disclose
 
Richard T. Penson
Honoraria - Abbvie; AstraZeneca; Clovis Oncology; Eisai Inc.; Genentech/Roche; Janssen Oncology (J&J); Mersana Therapeutics, Inc.; Newlink Genetics; Sutro Biopharma; Tesaro Inc.; Vascular Biogenics Ltd
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Baxalta; Care4ward; Clovis Oncology; Eisai; Genentech; Janssen Oncology; Merck; Mersana; Sutro; Tesaro; Vascular Biogenics
Research Funding - Array BioPharma (Inst); AstraZeneca (Inst); Cerulean Pharma (Inst); Eisai (Inst); Genentech (Inst); Regeneron (Inst); Sanofi (Inst); Tesaro (Inst); Vascular Biogenics (Inst)
Patents, Royalties, Other Intellectual Property - Blackwell Publishing; BMJ; UpToDate
Travel, Accommodations, Expenses - AstraZeneca; Clovis Oncology; Genentech; Tesaro; Vascular Biogenics
Other Relationship - Abbvie
 
Amit M. Oza
Honoraria - Intas
Consulting or Advisory Role - Immunogen; Merck KGaA
Research Funding - AstraZeneca (Inst); Immunovaccine (Inst)
Travel, Accommodations, Expenses - AstraZeneca
Other Relationship - AstraZeneca; Clovis Oncology; Clovis Oncology; Merck; Tesaro
 
Jacob Korach
Consulting or Advisory Role - AstraZeneca; MSD Oncology
 
Tomasz Huzarski
Employment - Read-Gene
 
Sandro Pignata
Honoraria - AstraZeneca; MSD; pfizer; pharmamar; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Pfizer; PharmaMar; Roche; tesaro
Research Funding - AstraZeneca (Inst); MSD (Inst); Pfizer (Inst); Roche (Inst)
 
Michael Friedlander
Honoraria - AstraZeneca; Lilly; MSD; Novartis; Takeda
Consulting or Advisory Role - Abbvie; AstraZeneca; Lilly; MSD; Novartis; Takeda
Speakers' Bureau - ACT Genomics; AstraZeneca
Research Funding - AstraZeneca (Inst); BeiGene (Inst)
Travel, Accommodations, Expenses - AstraZeneca
 
Alessandra Baldoni
No Relationships to Disclose
 
Tjoung-Won Park-Simon
Honoraria - AstraZeneca; Lilly; Novartis; Pfizer; Roche; Tesaro
Consulting or Advisory Role - AstraZeneca; Hexal; Lilly; Roche; Tesaro
Travel, Accommodations, Expenses - AstraZeneca; Lilly; Pfizer; Roche; Tesaro
 
Gabe S. Sonke
Consulting or Advisory Role - Novartis (Inst)
Research Funding - AstraZeneca (Inst); Merck Sharp & Dohme (Inst); Novartis (Inst); Roche (Inst)
 
Alla Sergeevna Lisyanskaya
Honoraria - AstraZeneca (Inst); INCURON (Inst); MSD (Inst); REGENERON (Inst); Roche (Inst)
Research Funding - AstraZeneca; INCURON; MSD; Regeneron; Roche
 
Jae-Hoon Kim
No Relationships to Disclose
 
Elias Abdo Filho
No Relationships to Disclose
 
Ignace Vergote
Consulting or Advisory Role - Amgen Europe (Inst); AstraZeneca (Inst); Carrick Therapeutics (Inst); Clovis Oncology (Inst); Debiopharm Group (Inst); F. Hoffmann La Roche (Inst); Genmab (Inst); GSK Pharmaceuticals (Inst); Immunogen (Inst); Medical University of Vienna (Inst); Millennium (Inst); MSD Belgium (Inst); Octimet Oncology (Inst); Oncoinvent (Inst); PharmaMar (Inst); Roche (Inst); Sotio (Inst); Tesaro (Inst)
Research Funding - Amgen (Inst); Genmab (Inst); Oncoinvent (Inst); Roche (Inst)
Travel, Accommodations, Expenses - Amgen; AstraZeneca; MSD/ Merck Zurich + USA; Roche; Tesaro
 
Phil Rowe
Employment - AstraZeneca
 
Eric Pujade-Lauraine
Honoraria - AstraZeneca; GSK; Tesaro
Consulting or Advisory Role - AstraZeneca; Clovis Oncology; Incyte; Merck; Pfizer/EMD Serono; Roche; TESARO
Travel, Accommodations, Expenses - AstraZeneca; Roche; Tesaro
Other Relationship - ARCAGY RESEARCH